Synageva attracts additional $12m to venture funding round

22 Oct 2009

Synageva BioPharma a Massachusetts developer of protein therapeutics has raised $12m in new Series F venture funding. New investor New Leaf Venture Partners joined existing backers Hunt BioVentures, Yasuda Enterprise Development, Baker Brothers Investments, Tullis Dickerson and Four Partners. The latest capital commitments bring the round total to $45m.

Sorry, to read the full story you must be a Premium Subscriber

Are you a subscriber?

In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.

Become a Premium Subscriber
for only £150 / €180 / $225 p.a.

Login area

If you are already a AltAssets subscriber please log in below.

NEWS & VIEWS

Global private equity and venture capital news and research

By News Type

By PE Sector

By Region

By Region

Country Focus

PE Focus

Industry Focus

Other

AltAssets Events

Industry Events